YOU ARE HERE:
Pharmacokinetics news
page  of 4
 
Headline
Date
  Maraviroc showing tantalising promise as microbicide in preclinical studies
19.02.10
  Elvitegravir 'Quad' pill performs well, new booster cobicistat works as well as ritonavir
18.02.10
  Rifabutin dose inadequate alongside Kaletra
16.10.09
  Stopping efavirenz due to CNS side-effects not associated with blood levels of the drug
14.10.09
  50mg of ritonavir may be an effective booster for some protease inhibitors
13.10.09
  Tobacco, marijuana and alcohol may lower levels of some anti-HIV drugs
21.09.09
  GS-9350 boosts atazanavir just as well as ritonavir
21.09.09
  Don't take Ginkgo biloba with efavirenz
21.05.09
  Once-a-day etravirine should work as first-line treatment
16.11.08
  One in five Kenyan patients suffers major interactions with HIV drugs
13.11.08
  Starting HIV treatment soon after a patient is diagnosed with cryptococcal meningitis decreases risk of death
03.11.08
  Plasma concentrations of rifampicin may be too low in children using currently recommended doses
31.10.08
  Heat-stable ritonavir tablet equivalent to soft gel capsule; may be approved next year
15.08.08
  Gilead now testing ritonavir replacement in human studies
23.07.08
  Nucleoside levels in seminal fluid higher than in blood, but not inside cells
18.06.08
  Combining rifampicin with increased doses of lopinavir/ritonavir tablets leads to dangerous increases in liver enzymes
13.05.08
  BHIVA: Concerns over confidentiality, drug interactions, communication, barriers to integrating GPs into HIV care
02.05.08
  Unexpected drug interaction found between Kaletra and rosuvastatin
17.04.08
  CROI: TDM-based PI dose escalation shows modest benefit in black and Hispanic, but not Caucasian, treatment-experienced patients
06.02.08
  Kaletra monotherapy studies yield conflicting results
28.01.08

page  of 4